Active substance
Isoprenaline
- SFDA 4
- US FDA 39
- Health Canada 3
- Safety 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Vascorin | 0.2 mg/ml | Solution for injection/infusion · Intravenous use | 1 Vial | SAR 237.20 | Generic · Prescription | ALPHA PHARMA INDUSTRY | Valid |
| Vascorin | 0.2 mg/ml | Solution for injection/infusion · Intravenous use | 5 Vial | SAR 118.60 | Generic · Prescription | ALPHA PHARMA INDUSTRY | Valid |
| ISOPROTERENOL HCL EMERG.1:5000 SYRING | Solution for injection · Intravenous use | 1 Pre-filled syringe | SAR 22.65 | NCE · Prescription | HOSPIRA INC | Withdrawn by MAH · Not Marketed | |
| ISOPROTERENOL1:5000 ADDIT EMER.SYRING | Solution for injection · Intravenous use | 1 Pre-filled syringe | SAR 21.05 | NCE · Prescription | HOSPIRA INC | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | NEXUS | Prescription | 2 Aug 2017 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | AMPHASTAR PHARMS INC | Prescription | 18 Jun 2018 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | AMNEAL | Prescription | 17 Oct 2018 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | MICRO LABS | Prescription | 16 Feb 2021 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | J MOLNER | Prescription | 19 May 2021 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | AVET LIFESCIENCES | Prescription | 19 Nov 2021 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | PENN LIFE | Prescription | 20 Sep 2022 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | HIKMA PHARMS | Prescription | 26 Apr 2023 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | SOMERSET THERAPS LLC | Prescription | 6 Aug 2024 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | GLAND | Prescription | 3 Oct 2024 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | DEVA HOLDING AS | Prescription | 10 Dec 2025 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | ASPIRO | Prescription | 18 May 2026 |
| ISUPREL | 10MG; 15MG | tablet · rectal, sublingual | SANOFI AVENTIS US | Discontinued | 19 Feb 1948 |
| MEDIHALER-ISO | 0.08MG/INH | aerosol, metered · inhalation | 3M | Discontinued | 9 Mar 1956 |
| ISOPROTERENOL HYDROCHLORIDE | 0.12MG/INH | aerosol, metered · inhalation | 3M | Discontinued | 9 Mar 1956 |
| ISUPREL | 0.2MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | BAUSCH | Discontinued | 25 May 1956 |
| ISOPROTERENOL HYDROCHLORIDE | 0.02MG/ML | injectable · injection | HOSPIRA | Discontinued | 15 Nov 1974 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | BAXTER HLTHCARE | Discontinued | 15 Nov 1974 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | HOSPIRA | Discontinued | 15 Jul 1975 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | INTL MEDICATION | Discontinued | 6 Jan 1976 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | CIPLA | Discontinued | 12 Jun 2018 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | CIPLA | Discontinued | 28 Jun 2019 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | EUGIA PHARMA | Discontinued | 9 Feb 2021 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | PHARMOBEDIENT | Discontinued | 6 Sep 2022 |
| ISOPROTERENOL HYDROCHLORIDE | 0.2MG/ML | injectable · injection | AM REGENT | Discontinued | 19 Oct 2022 |
14 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ISOPROTERENOL HYDROCHLORIDE INJECTION USP | 00897639 | 0.2 MG / ML | SOLUTION · SUBCUTANEOUS; INTRAVENOUS; INTRAMUSCULAR | SANDOZ CANADA INCORPORATED |
| ISOPROTERENOL HYDROCHLORIDE INJECTION USP | 02502615 | 0.2 MG / ML | SOLUTION · SUBCUTANEOUS; INTRAMUSCULAR; INTRAVENOUS | MARCAN PHARMACEUTICALS INC |
| ISOPROTERENOL HYDROCHLORIDE INJECTION USP | 02502623 | 1 MG / 5 ML | SOLUTION · SUBCUTANEOUS; INTRAMUSCULAR; INTRAVENOUS | MARCAN PHARMACEUTICALS INC |
Safety signals and safety-related labeling changes
- US FDA 20 Oct 2022 ISUPREL — safety-related labeling change
Labeling sections changed: Use in Specific Populations
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.